Oncolytics Biotech Inc (ONCY): Cash & Equivalents
$5.20M
As of 2025-12-31
$4.12M
As of 2026-06-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.20M | -53.0% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $11.08M | n/a | 2026-03-30, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Oncolytics Biotech Inc (ONCY) | 2025-12-31 | $5.20M | -53.0% |
| Rocket One Inc. (RKTO) | 2025-12-31 | $6.25M | -11.2% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $4.75M | +21.6% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $4.31M | +23.1% |
| Processa Pharmaceuticals, Inc. (PCSA) | 2025-12-31 | $5.54M | +364.8% |
| Dermata Therapeutics, Inc. (DRMA) | 2025-12-31 | $7.52M | +137.9% |
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | $4.00M | -45.1% |
| GT Biopharma, Inc. (GTBP) | 2025-12-31 | $6.81M | +72.4% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $1.8K | -16.3% |
Compare ONCY, RKTO, SILO, ENSC side by side · Screen every company in Pharmaceutical Preparations ↗